A team of researchers is using breakthrough gene-editing technology to develop a new screening tool for Parkinson’s disease, a debilitating degenerative disorder of the nervous system. The technology allows scientists in the lab to ‘light up’ and then monitor a brain protein called alpha-synuclein that has been associated with Parkinson’s.